Latest David Samadi Stories
NEW YORK, Oct. 11, 2011 /PRNewswire/ -- This week we await the official no-PSA recommendation from the United States Preventive Services Task Force (USPSTF), but the backlash is well underway. Based on concerns that further testing and even treatment may cause more harm than good, the panel of primary care physicians plans to advise all healthy men to avoid annual PSA screenings for prostate cancer. (Photo: http://photos.prnewswire.com/prnh/20111011/NY84661 ) In press and public outcry,...
NEW YORK, Sept. 29, 2011 /PRNewswire/ -- This spring Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, delivered a prostate cancer cure to Curtis Sliwa, founder of the Guardian Angels. After a year of unsuccessful holistic treatments for prostate cancer, Sliwa underwent robotic prostatectomy surgery in the care of Dr. Samadi, a somewhat difficult procedure given Sliwa's prior abdominal surgeries....
NEW YORK, Sept. 27, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, has performed over 3,500 robotic prostatectomy procedures in the past ten years for prostate cancer. Robotics is among the latest buzzwords across a wide range of medical specialties. With regard to prostate cancer treatment, the options are vast and the names can often be confusing. For example, robotic...
NEW YORK, Sept. 10, 2011 /PRNewswire/ -- September marks Prostate Cancer Awareness Month, and as a result, women throughout the United States have a valuable addition to the infamous honey-do list. As the second leading cause of death in U.S. men, prostate cancer will affect close to 218,000 this year, many with almost no symptoms. Sadly, 32,000 of those men will succumb to the disease. What Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive...
NEW YORK, Sept. 7, 2011 /PRNewswire/ -- During Prostate Cancer Awareness Month, researchers will publish the findings of two studies examining the use, or overuse, of scans in determining the status or level of a patient's prostate cancer after diagnosis. "Typically, patients with an elevated PSA level undergo a prostate biopsy to confirm the presence of cancer. Following the official diagnosis, the doctor must then evaluate whether the cancer is localized or if it has already spread to...
NEW YORK, Sept. 2, 2011 /PRNewswire/ -- This September, during Prostate Cancer Awareness Month, there is talk of a new prostate cancer screening method that may change the face of prostate cancer diagnoses. Initial data gathered by two Cleveland hospitals and one Boston hospital, analyzed by the National Cancer Institute, indicates significantly more accurate results with a new urine screening. Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally...
NEW YORK, Aug. 31, 2011 /PRNewswire/ -- The findings of an NYU Langone Medical Center questionnaire were recently published in the Journal of Urology, indicating that one in eight men experience climacturia, defined as sexual incontinence or the leaking of urine during sex and climax, following open prostate surgery for the treatment of localized prostate cancer. Dr. David Samadi is a robotic prostatectomy expert and Vice Chairman, Department of Urology, and Chief of Robotics and Minimally...
NEW YORK, Aug. 17, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center knows the wide range of emotions and fears that men with prostate cancer face. As a robotic prostatectomy and prostate cancer treatment expert, Dr. Samadi cares for the total patient, helping them deal with all aspects of treatment, recovery and cure. Robotic prostatectomy procedures, performed to remove the...
NEW YORK, Aug. 13, 2011 /PRNewswire/ -- Robotics are helping surgeons make great strides in the medical arena, and the advanced technology used in robotic prostatectomy procedures delivers many benefits to both surgeon and patient. However, in recent news, there is some scrutiny on the frequency of its use. Further, some critics are cautioning patients against the mass marketing of robotic surgery and its benefits. Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of...
NEW YORK, Aug. 12, 2011 /PRNewswire/ -- Prostate Specific Antigen (PSA) screening is the universal standard for early detection of prostate cancer in men. The medical community, and even the press, routinely urge men to begin PSA testing at age 50, and even earlier - age 40 - for high risk men, including African Americans or those with a family history of prostate cancer. Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The...
